Findings of reduced risks for mortality and major CVD suggest consideration of statins in all adults with type 2 diabetes, even in those with low short-term predicted CVD risk.

The target trial emulation study suggests rigid risk thresholds aren’t needed to steer statin use in this group.

Please provide your email address to receive an email when new articles are posted on . Although lipid-lowering medications are generally well tolerated, rare complications can include ...

BUFFALO, NY. – Approximately 200,000 of the 38 million people in the U.S. who take statins to treat high cholesterol may develop life-threatening muscle disease. Currently there is no comprehensive ...

Statin therapy does not exacerbate muscle injury, pain or fatigue in people engaging in moderate-intensity exercise, such as walking, according to a study published today in the Journal of the ...

Cardiologists have known for more than three decades that statin-type cholesterol-lowering drugs can lower levels of ubiquinone. Most people know ubiquinone by the name coenzyme Q10 or CoQ10.

The Physicians’ Desk Reference for Herbal Medicines has a discussion of how the statins may inhibit natural synthesis of coenzyme Q, placing a patient at risk for statin myopathy. Has a benefit been ...

A large cohort study found that statins significantly reduce the risk of death and major cardiovascular events in adults with ...